Prof Kamlesh Khunti(@kamleshkhunti) 's Twitter Profileg
Prof Kamlesh Khunti

@kamleshkhunti

Professor of Primary Care Diabetes & Vascular Medicine, GP, University of Leicester

ID:2345299433

linkhttps://bit.ly/2Rmv4LV calendar_today15-02-2014 17:47:10

23,3K Tweets

22,4K Followers

420 Following

Prof Kamlesh Khunti(@kamleshkhunti) 's Twitter Profile Photo

Combination of GLP-1 receptor agonist & SGLT-2 inhibitor

Associated with a ⬇️ risk of major adverse cardiovascular events & serious kidney events compared with either drug class alone

The BMJ

bmj.com/content/bmj/38…

Combination of GLP-1 receptor agonist & SGLT-2 inhibitor Associated with a ⬇️ risk of major adverse cardiovascular events & serious kidney events compared with either drug class alone @bmj_latest bmj.com/content/bmj/38…
account_circle
Prof Kamlesh Khunti(@kamleshkhunti) 's Twitter Profile Photo

⬆️ intake of ultra-processed foods associated with higher all cause mortality

Driven by causes other than cancer and cardiovascular diseases

>30 yr follow-up study

bmj.com/content/385/bm…

⬆️ intake of ultra-processed foods associated with higher all cause mortality Driven by causes other than cancer and cardiovascular diseases >30 yr follow-up study bmj.com/content/385/bm…
account_circle
Prof Kamlesh Khunti(@kamleshkhunti) 's Twitter Profile Photo

The U.S. FDA has granted clearance to Diagnostic Screening technology for diagnosing referable diabetic retinopathy.

medicaldialogues.in/ophthalmology/…

The @US_FDA has granted clearance to Diagnostic Screening technology for diagnosing referable diabetic retinopathy. medicaldialogues.in/ophthalmology/…
account_circle
Prof Kamlesh Khunti(@kamleshkhunti) 's Twitter Profile Photo

A useful review for primary care

Detecting and managing the patient with chronic kidney disease in primary care

dom-pubs.onlinelibrary.wiley.com/doi/full/10.11…

A useful review for primary care Detecting and managing the patient with chronic kidney disease in primary care dom-pubs.onlinelibrary.wiley.com/doi/full/10.11…
account_circle
Prof Kamlesh Khunti(@kamleshkhunti) 's Twitter Profile Photo

GLP1-RAs modestly reduced BP in people with and without T2 diabetes: A meta-analysis and meta-regression

Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 et al

dom-pubs.onlinelibrary.wiley.com/doi/full/10.11…

GLP1-RAs modestly reduced BP in people with and without T2 diabetes: A meta-analysis and meta-regression @DrMarthaGulati et al dom-pubs.onlinelibrary.wiley.com/doi/full/10.11…
account_circle
Prof Kamlesh Khunti(@kamleshkhunti) 's Twitter Profile Photo

More data to support simple improvements in cardiovascular health

Associated with lower multiple long term conditions (multimorbidity)

sciencedirect.com/science/articl…

More data to support simple improvements in cardiovascular health Associated with lower multiple long term conditions (multimorbidity) sciencedirect.com/science/articl…
account_circle
India in Birmingham(@CGI_Bghm) 's Twitter Profile Photo

Great meeting of CG Venkatachalam M with VC Nishan Canagarajah at University of Leicester! CG was keen to learn about the partnership prog delivered by University of Leicester & Apollo University (TAU), part of the Apollo Hospitals Group along with the array of ongoing & projects with 🇮🇳

Great meeting of CG @venkatifs with VC @NCanagarajah at @uniofleicester! CG was keen to learn about the partnership prog delivered by @uniofleicester & Apollo University (TAU), part of the Apollo Hospitals Group along with the array of ongoing #Space & #Medicine projects with 🇮🇳
account_circle
BMJ Open Diabetes Research & Care journal(@DiabetesRC) 's Twitter Profile Photo

Cost-effectiveness analysis of two interventions to promote physical activity in a multiethnic population at high risk of diabetes💲 🏃 Prof Kamlesh Khunti

Learn more from this economic evaluation of the 48-month PROPELS trial
👇
bit.ly/3IVabla

Cost-effectiveness analysis of two interventions to promote physical activity in a multiethnic population at high risk of diabetes💲 🏃 @kamleshkhunti Learn more from this economic evaluation of the 48-month PROPELS trial 👇 bit.ly/3IVabla
account_circle
Prof Kamlesh Khunti(@kamleshkhunti) 's Twitter Profile Photo

Our emulation target trial of second line therapies in people with T2 diabetes The BMJ

SGLT2i, DPP4i and SUs

Led by Patrick Bidulka London School of Hygiene & Tropical Medicine

bmj.com/content/385/bm…

Our emulation target trial of second line therapies in people with T2 diabetes @bmj_latest SGLT2i, DPP4i and SUs Led by Patrick Bidulka @LSHTM bmj.com/content/385/bm…
account_circle
Prof Kamlesh Khunti(@kamleshkhunti) 's Twitter Profile Photo

Review

The role of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatohepatitis

dom-pubs.onlinelibrary.wiley.com/doi/full/10.11…

Review The role of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatohepatitis dom-pubs.onlinelibrary.wiley.com/doi/full/10.11…
account_circle
NIHR ARC East Midlands(@ARC_EM) 's Twitter Profile Photo

Exciting updates across NIHR Applied Research Collaborations (ARCs)!

Featuring NIHR ARC East Midlands’s:
🔎Research: Ethnic minorities underrepresented in MLTCs studies
✅Workshops on equality impact assessment
💡Symposium on advancing equality in MLTCs research
💻Free training courses
Prof Kamlesh Khunti

account_circle
🌱Leicester Diabetes(@LDC_tweets) 's Twitter Profile Photo

Are you interested in a study that will test a new type of care that has been specifically designed for people with -related foot ulcer disease? You may be eligible for the MiFoot study: mifoot.org.uk
Prof Kamlesh Khunti Pratik Choudhary Melanie

Are you interested in a #research study that will test a new type of care that has been specifically designed for people with #diabetes-related foot ulcer disease? You may be eligible for the MiFoot study: mifoot.org.uk @kamleshkhunti @drpratikc @profmjdavies
account_circle
Prof Kamlesh Khunti(@kamleshkhunti) 's Twitter Profile Photo

Placebo-controlled trial

Outpatient treatment of SARS-CoV-2 with metformin significantly reduced SARS-CoV-2 viral load

Metformin keeps giving!

John Buse et al

academic.oup.com/cid/advance-ar…

Placebo-controlled trial Outpatient treatment of SARS-CoV-2 with metformin significantly reduced SARS-CoV-2 viral load Metformin keeps giving! @busediabetes et al academic.oup.com/cid/advance-ar…
account_circle
Prof Kamlesh Khunti(@kamleshkhunti) 's Twitter Profile Photo

Combination of SGLT2is + GLP-1RAs associated with lower all-cause mortality & improvements in cardiovascular, renal, and glycemic measurements.

Systematic review and meta-analysis of observational studies

Combination of SGLT2is + GLP-1RAs associated with lower all-cause mortality & improvements in cardiovascular, renal, and glycemic measurements. Systematic review and meta-analysis of observational studies
account_circle
Prof Kamlesh Khunti(@kamleshkhunti) 's Twitter Profile Photo

GLP1 receptor agonist use not associated with a increased risk of thyroid cancer
The BMJ

Mean follow-up of ~4 years

Large multinational cohort study

bmj.com/content/385/bm…

GLP1 receptor agonist use not associated with a increased risk of thyroid cancer @bmj_latest Mean follow-up of ~4 years Large multinational cohort study bmj.com/content/385/bm…
account_circle